ThruFlo Endovascular

ThruFlo Endovascular is a private neuro-endovascular medical device company developing a first-in-class dual-limb flow diverter for bifurcation aneurysms and other complex intracranial aneurysms. The company is focused on minimally invasive endovascular treatment of life-threatening neurovascular conditions that are not well served by existing side-wall flow diverters or coil-based approaches. Its lead technology is a proprietary bifurcated, Y-shaped flow diverter designed to span the aneurysm neck at arterial branch points while preserving daughter vessel access and perfusion. As of June 10, 2026, the company describes itself as clinical-stage, but publicly available details indicate it is still generating pre-clinical evidence and preparing for an FDA IDE submission. ThruFlo recently announced seed financing to support formal R&D, final device design, additional pre-clinical studies, and regulatory preparation.